SUPEXZO
LIVE

Serial Number

79393765

Owner

TAIHO PHARMACEUTICAL CO., LTD.

Filing Date

Feb 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SUPEXZO Trademark

Serial Number: 79393765 • Registration: 7602738

SUPEXZO is a trademark filed by TAIHO PHARMACEUTICAL CO., LTD. on February 13, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

TAIHO PHARMACEUTICAL CO., LTD. (107 trademarks)

CHIYODA-KU, TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

February 13, 2024

Registration Date

December 17, 2024

Published for Opposition

October 15, 2024

Goods & Services

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 17, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 17, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 16, 2025 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTICE OF PUBLICATION
Sep 25, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 6, 2024 CNSA
ASSIGNED TO EXAMINER
Sep 5, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 7, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 26, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 18, 2024 REPR